아이오반스 바이오테라퓨틱스 (Iovance Biotherapeutics, Inc., IOVA): 편집 역사

차이 선택: 비교하려는 판의 라디오 버튼을 선택한 다음 엔터나 아래의 버튼을 누르세요.
설명: (최신) = 최신 판과 비교, (이전) = 이전 판과 비교, 잔글= 사소한 편집

2024년 12월 19일 (목)

2024년 12월 18일 (수)

2024년 12월 17일 (화)

2024년 12월 15일 (일)

2024년 12월 14일 (토)

2024년 12월 13일 (금)

2024년 12월 12일 (목)

2024년 12월 11일 (수)

2024년 12월 10일 (화)

2024년 12월 9일 (월)

2024년 12월 8일 (일)

2024년 11월 12일 (화)

2024년 10월 28일 (월)

  • 최신이전 15:372024년 10월 28일 (월) 15:37Ks.park 토론 기여 13,296 바이트 −549 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and... 태그: 수동 되돌리기

2024년 10월 27일 (일)

  • 최신이전 15:362024년 10월 27일 (일) 15:36Ks.park 토론 기여 13,845 바이트 +15 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 10월 26일 (토)

  • 최신이전 15:372024년 10월 26일 (토) 15:37Ks.park 토론 기여 13,830 바이트 −9 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 10월 25일 (금)

  • 최신이전 15:372024년 10월 25일 (금) 15:37Ks.park 토론 기여 13,839 바이트 +543 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 10월 24일 (목)

2024년 10월 20일 (일)

2024년 10월 10일 (목)

  • 최신이전 15:062024년 10월 10일 (목) 15:06Ks.park 토론 기여 13,126 바이트 +47 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...
  • 최신이전 06:022024년 10월 10일 (목) 06:02Ks.park 토론 기여 13,079 바이트 +283 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 10월 7일 (월)

  • 최신이전 15:352024년 10월 7일 (월) 15:35Ks.park 토론 기여 12,796 바이트 −466 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and... 태그: 수동 되돌리기

2024년 10월 6일 (일)

  • 최신이전 15:342024년 10월 6일 (일) 15:34Ks.park 토론 기여 13,262 바이트 −167 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 10월 5일 (토)

  • 최신이전 15:352024년 10월 5일 (토) 15:35Ks.park 토론 기여 13,429 바이트 −29 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 10월 4일 (금)

  • 최신이전 15:362024년 10월 4일 (금) 15:36Ks.park 토론 기여 13,458 바이트 +662 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 19일 (목)

  • 최신이전 15:362024년 9월 19일 (목) 15:36Ks.park 토론 기여 12,796 바이트 −435 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and... 태그: 수동 되돌리기

2024년 9월 18일 (수)

  • 최신이전 15:372024년 9월 18일 (수) 15:37Ks.park 토론 기여 13,231 바이트 −18 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 17일 (화)

  • 최신이전 15:352024년 9월 17일 (화) 15:35Ks.park 토론 기여 13,249 바이트 +14 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 16일 (월)

  • 최신이전 15:342024년 9월 16일 (월) 15:34Ks.park 토론 기여 13,235 바이트 +439 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 9일 (월)

  • 최신이전 15:352024년 9월 9일 (월) 15:35Ks.park 토론 기여 12,796 바이트 −424 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and... 태그: 수동 되돌리기

2024년 9월 8일 (일)

  • 최신이전 15:342024년 9월 8일 (일) 15:34Ks.park 토론 기여 13,220 바이트 −14 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 7일 (토)

  • 최신이전 15:352024년 9월 7일 (토) 15:35Ks.park 토론 기여 13,234 바이트 −357 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 6일 (금)

  • 최신이전 15:362024년 9월 6일 (금) 15:36Ks.park 토론 기여 13,591 바이트 −18 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 5일 (목)

  • 최신이전 15:352024년 9월 5일 (목) 15:35Ks.park 토론 기여 13,609 바이트 +35 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 4일 (수)

  • 최신이전 15:352024년 9월 4일 (수) 15:35Ks.park 토론 기여 13,574 바이트 +378 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 9월 3일 (화)

  • 최신이전 15:352024년 9월 3일 (화) 15:35Ks.park 토론 기여 13,196 바이트 +400 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 8월 30일 (금)

  • 최신이전 15:362024년 8월 30일 (금) 15:36Ks.park 토론 기여 12,796 바이트 −570 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and... 태그: 수동 되돌리기

2024년 8월 29일 (목)

  • 최신이전 15:362024년 8월 29일 (목) 15:36Ks.park 토론 기여 13,366 바이트 −2 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 8월 28일 (수)

  • 최신이전 16:152024년 8월 28일 (수) 16:15Ks.park 토론 기여 13,368 바이트 +6 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 8월 27일 (화)

  • 최신이전 15:352024년 8월 27일 (화) 15:35Ks.park 토론 기여 13,362 바이트 +566 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 8월 2일 (금)

  • 최신이전 20:192024년 8월 2일 (금) 20:19Ks.park 토론 기여 12,796 바이트 −325 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and... 태그: 수동 되돌리기

2024년 8월 1일 (목)

  • 최신이전 20:192024년 8월 1일 (목) 20:19Ks.park 토론 기여 13,121 바이트 −551 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 7월 31일 (수)

  • 최신이전 20:222024년 7월 31일 (수) 20:22Ks.park 토론 기여 13,672 바이트 +34 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 7월 30일 (화)

  • 최신이전 20:192024년 7월 30일 (화) 20:19Ks.park 토론 기여 13,638 바이트 +291 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 7월 29일 (월)

  • 최신이전 20:182024년 7월 29일 (월) 20:18Ks.park 토론 기여 13,347 바이트 +551 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 7월 23일 (화)

  • 최신이전 20:202024년 7월 23일 (화) 20:20Ks.park 토론 기여 12,796 바이트 −391 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and... 태그: 수동 되돌리기

2024년 7월 22일 (월)

  • 최신이전 20:202024년 7월 22일 (월) 20:20Ks.park 토론 기여 13,187 바이트 −26 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 7월 21일 (일)

  • 최신이전 20:202024년 7월 21일 (일) 20:20Ks.park 토론 기여 13,213 바이트 +417 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 7월 9일 (화)

  • 최신이전 22:452024년 7월 9일 (화) 22:45Ks.park 토론 기여 12,796 바이트 +21 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...

2024년 7월 3일 (수)

  • 최신이전 01:542024년 7월 3일 (수) 01:54Ks.park 토론 기여 12,775 바이트 +12,775 There is no specific information available in the documents provided regarding the business description of IOVA. Hence, I will provide you with a general overview of the company. IOVA is a biotechnology company that focuses on developing novel cancer immunotherapies. Their main expertise lies in utilizing T-cell therapy to treat various types of cancers. T-cell therapy involves modifying a patient’s immune cells to better recognize and target cancer cells, which can lead to more effective and...